SP 12008Alternative Names: SP12008
Latest Information Update: 09 Sep 2016
At a glance
- Originator Spherium Biomed
- Class Immunoproteins
- Mechanism of Action Immunomodulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preclinical Autoimmune disorders; Systemic lupus erythematosus